These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

792 related articles for article (PubMed ID: 32854645)

  • 1. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
    Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
    BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Develop a Novel Signature to Predict the Survival and Affect the Immune Microenvironment of Osteosarcoma Patients: Anoikis-Related Genes.
    Yang M; Su Y; Xu K; Zheng H; Cai Y; Wen P; Yang Z; Liu L; Xu P
    J Immunol Res; 2024; 2024():6595252. PubMed ID: 39431237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive investigation of tumor immune microenvironment and prognostic biomarkers in osteosarcoma through integrated bulk and single-cell transcriptomic analysis.
    Shi S; Zhang L; Guo X
    Front Immunol; 2024; 15():1424950. PubMed ID: 39108264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of CD8 Tex cell-associated gene signatures in the prognosis and immunology of osteosarcoma.
    Lu Y; Cao N; Zhao M; Zhang G; Zhang Q; Wang L
    Sci Rep; 2024 Apr; 14(1):9769. PubMed ID: 38684858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma.
    Yang H; Zhao L; Zhang Y; Li FF
    Cancer Med; 2021 Aug; 10(16):5696-5711. PubMed ID: 34258887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of TNFRSF1A as a potential biomarker for osteosarcoma.
    Zhang Y; Liu K; Wang J
    Cancer Biomark; 2024; 39(4):299-312. PubMed ID: 38250759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
    Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
    Front Immunol; 2021; 12():806189. PubMed ID: 35095893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Hypoxia Gene-Based Signature to Predict the Survival and Affect the Tumor Immune Microenvironment of Osteosarcoma in Children.
    Jiang F; Miao XL; Zhang XT; Yan F; Mao Y; Wu CY; Zhou GP
    J Immunol Res; 2021; 2021():5523832. PubMed ID: 34337075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroptosis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma.
    Lei T; Qian H; Lei P; Hu Y
    Cancer Sci; 2021 Nov; 112(11):4785-4798. PubMed ID: 34506683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumor immune microenvironment and immune-related signature predict the chemotherapy response in patients with osteosarcoma.
    He L; Yang H; Huang J
    BMC Cancer; 2021 May; 21(1):581. PubMed ID: 34016089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of Prognosis and Immunotherapy Response with a Novel Natural Killer Cell Marker Genes Signature in Osteosarcoma.
    Li Q; Huang X; Zhao Y
    Cancer Biother Radiopharm; 2024 Sep; 39(7):502-516. PubMed ID: 37889617
    [No Abstract]   [Full Text] [Related]  

  • 13. Integrative analysis of immune-related multi-omics profiles identifies distinct prognosis and tumor microenvironment patterns in osteosarcoma.
    Shi D; Mu S; Pu F; Liu J; Zhong B; Hu B; Ni N; Wang H; Luu HH; Haydon RC; Shen L; Zhang Z; He TC; Shao Z
    Mol Oncol; 2022 Jun; 16(11):2174-2194. PubMed ID: 34894177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma.
    Wu G; Zhang M
    BMC Cancer; 2020 May; 20(1):456. PubMed ID: 32448271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Profiling of Alternative Splicing for Sarcoma Patients Reveals Novel Prognostic Biomarkers Associated with Tumor Microenvironment and Immune Cells.
    Hu C; Wang Y; Liu C; Shen R; Chen B; Sun K; Rao H; Ye L; Ye J; Tian S
    Med Sci Monit; 2020 Jul; 26():e924126. PubMed ID: 32683393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
    Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
    World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Novel Anoikis-Related Gene Signatures to Predict the Prognosis, Immune Microenvironment, and Drug Sensitivity of Breast Cancer Patients.
    Liu J; Wu H; Wang Q; Jin S; Hou S; Shen Z; Zhao L; Xu S; Pang D
    Cancer Control; 2024; 31():10732748241288118. PubMed ID: 39340434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma cancer.
    Liu R; Hu Y; Liu T; Wang Y
    BMC Cancer; 2021 Dec; 21(1):1345. PubMed ID: 34922489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A three-gene signature based on tumour microenvironment predicts overall survival of osteosarcoma in adolescents and young adults.
    Wen C; Wang H; Wang H; Mo H; Zhong W; Tang J; Lu Y; Zhou W; Tan A; Liu Y; Xie W
    Aging (Albany NY); 2020 Dec; 13(1):619-645. PubMed ID: 33281116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infiltration of LPAR5
    He Y; Zhou H; Huang X; Qu Y; Wang Y; Pei W; Zhang R; Chen S; You H
    Front Immunol; 2022; 13():909932. PubMed ID: 36591220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.